Biotech Target N V (CIK 0001259870)

Latest company ownership

MGNX - MACROGENICS INC
Role: 10% Owner
Shares held
9,929,963
Last filed at
Oct 4, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
4,477,964
Last filed at
May 26, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q2 2025Q4
Shares held
2,295,272
Last filed at
Nov 16, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 2, 2023 Oct 4, 2023 MACROGENICS INC 10% Owner Buy 85.0 +150,000 1.53% ✗ $669.6K
Sep 7, 2023 Sep 11, 2023 MACROGENICS INC 10% Owner Buy 87.5 +200,000 2.09% ✗ $1.1M
Feb 14, 2023 Feb 16, 2023 MACROGENICS INC 10% Owner Buy 95.0 +500,000 5.51% ✗ $2.5M
Jan 19, 2023 Jan 23, 2023 MACROGENICS INC 10% Owner Buy 85.0 +150,000 1.68% ✗ $794.9K
Dec 23, 2022 Dec 28, 2022 MACROGENICS INC 10% Owner Buy 92.5 +400,000 4.69% ✗ $2.3M
Nov 22, 2022 Nov 25, 2022 MACROGENICS INC 10% Owner Buy 92.5 +300,000 3.65% ✗ $1.8M
Oct 21, 2022 Oct 25, 2022 MACROGENICS INC 10% Owner Buy 95.0 +500,000 6.47% ✗ $2.2M
Oct 19, 2022 Oct 21, 2022 MACROGENICS INC 10% Owner Buy 95.0 +454,399 6.25% ✗ $1.8M
Nov 19, 2021 Nov 23, 2021 MACROGENICS INC 10% Owner Buy 92.5 +200,000 2.83% ✗ $3.7M
Sep 28, 2021 Sep 30, 2021 MACROGENICS INC 10% Owner Buy 92.5 +200,000 2.91% ✗ $4.1M
Sep 16, 2021 Sep 20, 2021 MACROGENICS INC 10% Owner Buy 97.5 +600,000 9.56% ✗ $12.4M
Jun 21, 2021 Jun 23, 2021 MACROGENICS INC 10% Owner Buy 87.5 +75,000 1.21% ✗ $1.6M
Jun 15, 2021 Jun 17, 2021 MACROGENICS INC 10% Owner Buy 92.5 +175,000 2.90% ✗ $3.6M
May 24, 2021 May 26, 2021 Esperion Therapeutics, Inc. 10% Owner Buy 87.5 +100,000 2.28% ✗ $2M
May 19, 2021 May 21, 2021 Esperion Therapeutics, Inc. 10% Owner Buy 92.5 +200,000 4.79% ✗ $4.1M
May 5, 2021 May 7, 2021 Esperion Therapeutics, Inc. 10% Owner Buy 95.0 +230,000 5.83% ✗ $4.6M
Nov 3, 2020 Nov 4, 2020 Esperion Therapeutics, Inc. 10% Owner Buy 96.3 +200,000 5.34% ✗ $5.1M
Jan 23, 2020 Jan 27, 2020 Esperion Therapeutics, Inc. 10% Owner Buy 77.5 +20,000 0.54% ✗ $1M
Nov 6, 2019 Nov 8, 2019 Esperion Therapeutics, Inc. 10% Owner Buy 87.5 +75,000 2.05% ✗ $2.8M
Sep 4, 2019 Sep 6, 2019 Esperion Therapeutics, Inc. 10% Owner Buy 87.5 +80,000 2.24% ✗ $2.7M
Jul 23, 2019 Jul 25, 2019 Esperion Therapeutics, Inc. 10% Owner Buy 87.5 +50,000 1.42% ✗ $2.1M
Mar 14, 2019 Mar 15, 2019 Esperion Therapeutics, Inc. 10% Owner Buy 87.5 +50,000 1.44% ✗ $2.5M
Jan 4, 2019 Jan 7, 2019 Esperion Therapeutics, Inc. 10% Owner Buy 87.5 +80,000 2.36% ✗ $3.3M
Dec 24, 2018 Dec 26, 2018 Esperion Therapeutics, Inc. 10% Owner Buy 87.5 +50,000 1.50% ✗ $2M
Dec 17, 2018 Dec 19, 2018 Esperion Therapeutics, Inc. 10% Owner Buy 87.5 +60,000 1.83% ✗ $2.9M
Aug 3, 2018 Aug 6, 2018 Esperion Therapeutics, Inc. 10% Owner Buy 87.5 +50,000 1.55% ✗ $2.3M
Jul 12, 2018 Jul 13, 2018 Esperion Therapeutics, Inc. 10% Owner Buy 87.5 +50,000 1.57% ✗ $2.1M
Jun 29, 2018 Jul 3, 2018 Esperion Therapeutics, Inc. 10% Owner Buy 87.5 +50,000 1.60% ✗ $2M
Jun 21, 2018 Jun 25, 2018 Esperion Therapeutics, Inc. 10% Owner Buy 87.5 +60,000 1.95% ✗ $2.3M
Jun 7, 2018 Jun 11, 2018 Esperion Therapeutics, Inc. 10% Owner Buy 87.5 +60,000 1.99% ✗ $2.3M
Jun 5, 2018 Jun 7, 2018 Esperion Therapeutics, Inc. 10% Owner Buy 87.5 +60,000 2.03% ✗ $2.3M
May 18, 2018 May 22, 2018 Esperion Therapeutics, Inc. 10% Owner Buy 93.8 +130,000 4.61% ✗ $5.2M
Nov 15, 2017 Nov 16, 2017 Cidara Therapeutics, Inc. 10% Owner Buy 90.0 +60,000 2.68% ✗ $454K